Walleye Capital LLC Acumen Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

  • $38.9 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.14 - $4.01 $40,234 - $75,392
18,801 New
18,801 $45,000
Q1 2023

May 15, 2023
BUY
$3.75 - $6.65 $684,930 - $1.21 Million
182,648 Added 1314.87%
196,539 $797,000
Q4 2022

Feb 14, 2023
BUY
$4.81 - $10.17 $66,815 - $141,271
13,891 New
13,891 $75,000

Others Institutions Holding ABOS

# of Institutions
81
Shares Held
40.6M
Call Options Held
28.6K
Put Options Held
76.4K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $56.3M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email